Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Braveheart Bio Inc | 0 | 21,826,024 | +21,826,024 | $0 | $440.89M | 41.57% | +$440.89M |
| Newamsterdam Pharma Company ORDINARY SHARES | 8,490,353 | 8,490,353 | 0 | $287.74M | $206.49M | 19.47% | -$81.25M |
| Korsana Biosciences Inc | 0 | 2,192,155 | +2,192,155 | $0 | $70.15M | 6.61% | +$70.15M |
| Vor Biopharma Inc.(VOR) | 4,117,354 | 3,405,279 | -712,075 | $75.80M | $64.97M | 6.13% | -$10.83M |
| Dyne Therapeutics, Inc.(DYN) | 3,848,256 | 3,586,796 | -261,460 | $85.47M | $57.78M | 5.45% | -$27.69M |
| Damora Therapeutics, Inc.(DMRA) | 2,441,000 | 2,441,000 | 0 | $63.49M | $51.94M | 4.90% | -$11.55M |
| Maplight Therapeutics Inc | 3,226,400 | 4,428,328 | +1,201,928 | $115.63M | $45.12M | 4.25% | -$70.51M |
| Aura Biosciences Inc | 4,053,775 | 5,248,841 | +1,195,066 | $28.78M | $32.96M | 3.11% | +$4.18M |
| Crescent Biopharma Inc. | 1,677,852 | 2,022,679 | +344,827 | $30.20M | $29.51M | 2.78% | -$690.4K |
| Replimune Group, Inc.(REPL) | 2,808,368 | 1,720,500 | -1,087,868 | $31.09M | $22.78M | 2.15% | -$8.31M |
| Engene Holdings Inc COM | 9,632,561 | 9,632,561 | 0 | $16.66M | $19.27M | 1.82% | +$2.60M |
| Bicycle Therapeutics PlcADS | 3,468,430 | 3,468,430 | 0 | $14.71M | $12.76M | 1.20% | -$1.94M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 64,087 | +64,087 | $0 | $5.04M | 0.47% | +$5.04M |
| Engene Holdings IncW EXP 10 31 2028 *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | $834.4K | $575.6K | 0.05% | -$258.7K |
| Lisata Therapeutics Inc | 0 | 297,478 | +297,478 | $0 | $428.4K | 0.04% | +$428.4K |